Literature DB >> 18922896

Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions.

Keltie L Dall1, Cinzia G Scarpini, Ian Roberts, David M Winder, Margaret A Stanley, Balaji Muralidhar, M Trent Herdman, Mark R Pett, Nicholas Coleman.   

Abstract

As the high-risk human papillomavirus (HPV) integrants seen in anogenital carcinomas represent the end-point of a clonal selection process, we used the W12 model to study the naturally occurring integration events that exist in HPV16-infected cervical keratinocytes before integrant selection. We performed limiting dilution cloning to identify integrants present in cells that also maintain episomes. Such integrants arise in a natural context and exist in a noncompetitive environment, as they are transcriptionally repressed by episome-derived E2. We found that integration can occur at any time during episome maintenance, providing biological support for epidemiologic observations that persistent HPV infection is a major risk factor in cervical carcinogenesis. Of 24 different integration sites isolated from a single nonclonal population of W12, 12 (50%) occurred within chromosome bands containing a common fragile site (CFS), similar to observations for selected integrants in vivo. This suggests that such regions represent relatively accessible sites for insertion of foreign DNA, rather than conferring a selective advantage when disrupted. Interestingly, however, integrants and CFSs did not accurately colocalize. We further observed that local DNA rearrangements occur frequently and rapidly after the integration event. The majority of integrants were in chromosome bands containing a cancer-associated coding gene or microRNA, indicating that integration occurs commonly in these regions, regardless of selective pressure. The cancer-associated genes were generally a considerable distance from the integration site, and there was no evidence for altered expression of nine strong candidate genes. These latter observations do not support an important role for HPV16 integration in causing insertional mutagenesis.

Entities:  

Mesh:

Year:  2008        PMID: 18922896     DOI: 10.1158/0008-5472.CAN-08-1741

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  The SMC5/6 Complex Interacts with the Papillomavirus E2 Protein and Influences Maintenance of Viral Episomal DNA.

Authors:  Peris Bentley; Min Jie Alvin Tan; Alison A McBride; Elizabeth A White; Peter M Howley
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

2.  In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.

Authors:  Elizabeth Gray; Mark R Pett; Dawn Ward; David M Winder; Margaret A Stanley; Ian Roberts; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

3.  Infection and integration of high-risk human papillomavirus in HPV-associated cancer cells.

Authors:  Chu-Yi Liu; Fan Li; Yi Zeng; Min-zhong Tang; Yulu Huang; Jin-Tao Li; Ru-Gang Zhong
Journal:  Med Oncol       Date:  2015-03-08       Impact factor: 3.064

4.  Characterization of the human papillomavirus (HPV) integration sites into genital cancers.

Authors:  Clorinda Annunziata; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Pathol Oncol Res       Date:  2012-03-27       Impact factor: 3.201

5.  Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq.

Authors:  Joseph D Khoury; Nizar M Tannir; Michelle D Williams; Yunxin Chen; Hui Yao; Jianping Zhang; Erika J Thompson; Funda Meric-Bernstam; L Jeffrey Medeiros; John N Weinstein; Xiaoping Su
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

6.  Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers.

Authors:  Il-Seok Park; Xiaofei Chang; Myriam Loyo; Gaosong Wu; Alice Chuang; Myoung Sook Kim; Young Kwang Chae; Sofia Lyford-Pike; William H Westra; John R Saunders; David Sidransky; Sara Isabel Pai
Journal:  Cancer Prev Res (Phila)       Date:  2011-02

7.  Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses.

Authors:  Jelizaveta Geimanen; Helen Isok-Paas; Regina Pipitch; Kristiina Salk; Triin Laos; Marit Orav; Tormi Reinson; Mart Ustav; Mart Ustav; Ene Ustav
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

8.  High-resolution genomic profiling of human papillomavirus-associated vulval neoplasia.

Authors:  K J Purdie; C A Harwood; K Gibbon; T Chaplin; B D Young; J B Cazier; N Singh; I M Leigh; C M Proby
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

Review 9.  Very large common fragile site genes and their potential role in cancer development.

Authors:  Ge Gao; David I Smith
Journal:  Cell Mol Life Sci       Date:  2014-10-10       Impact factor: 9.261

10.  DNA structure and the Werner protein modulate human DNA polymerase delta-dependent replication dynamics within the common fragile site FRA16D.

Authors:  Sandeep N Shah; Patricia L Opresko; Xiao Meng; Marietta Y W T Lee; Kristin A Eckert
Journal:  Nucleic Acids Res       Date:  2009-12-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.